UNSPSC 51172005: Fencibutirol

This classification denotes a cholagogue or choleretic agent with the molecular formula C16H22O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H2V165956A, chemically known as cyclohexaneacetic acid, alpha-ethyl-1-hydroxy-4-phenyl-, (+-)- but generally known as fencibutirol, which bears US NIH Compound Identifier 71170. European Medicines Agency schedules Fencibutirol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07547MIG.

UNSPSC 51172005 Fencibutirol is a Commodity code that captures pharmaceutical procurement by state and local government entities, though recent solicitation activity shows limited direct alignment with fencibutirol specifically. State and local buyers under this code range from county corrections departments and state health agencies to multistate cooperative purchasing alliances, procuring generic pharmaceuticals, over-the-counter products, and specialty testing services that may incorporate pharmaceutical screening methodologies. The issuing bodies include county community supervision and corrections departments (Collin County), state health and human services commissions (Texas HHS), and cooperative purchasing vehicles serving multiple state and local jurisdictions (Minnesota Multistate Cooperative Purchasing Alliance). Work solicited spans offender drug-testing programs with specimen collection and lab confirmation, direct-to-manufacturer prescription fulfillment initiatives, and multi-source generic pharmaceutical supply contracts for state and local facilities.

Recent activity appears concentrated in Texas and the Upper Midwest. Collin County Community Supervision and Corrections Department issued RFP 2026-327 for offender specimen collection and drug testing services due July 23, 2026, covering approximately 25,031 annual tests across two collection sites with an estimated contract value of $600,000 over two years plus three optional one-year renewals. The Texas Health and Human Services Commission posted RFI HHS0017013 on March 27, 2026 (response deadline April 3, 2026) to gather market intelligence on direct-to-manufacturer pharmacy programs before launching a formal procurement. The Minnesota Department of Administration's Office of State Procurement, administering the Minnesota Multistate Cooperative Purchasing Alliance, issued RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products with a proposal deadline of March 26, 2026, seeking manufacturers to provide NDC-specific pricing with products available through three authorized wholesalers and contract terms effective July 1, 2026. The code shows narrow recent activity; opportunities are sparse and geographically dispersed.